TOFA suppresses ovarian cancer cell growth in vitro and in vivo

By                

Molecular Medicine Reports, Vol. 8, Iss. 2, 2013-01 ,pp. : 373-378

Spandidos Publications

Access to resources Recommend Favorite

Paclitaxel disrupts polarized entry of membranepermeable C6 ceramide into ovarian cancer cells resulting in synchronous induction of cell death

By Best Charles   Calianese David   Szulak Kevin   Cammarata Garret   Brum Gabriella   Carbone Thomas   Still Eric   Higgins Katelyn   Ji Fang   Di Wen   Wanebo Harold   Wan Yinsheng  

Oncology Letters, Vol. 5, Iss. 6, 2013-06 ,pp. : 1854-1858

Spandidos Publications

Access to resources Recommend Favorite

Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells

By          

Oncology Reports, Vol. 33, Iss. 4, 2015-01 ,pp. : 1683-1690

Spandidos Publications

Access to resources Recommend Favorite

In vivo establishment and characterization of a paclitaxel-resistant human ovarian cancer cell line showing enhanced growth properties and drug-resistance only in vivo

By Okugawa Kaoru   Kobayashi Hiroaki   Hirakawa Toshio   Sonoda Takanori   Ogura Tomonori   Nakano Hitoo  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 3, 2004-03 ,pp. : 178-186

Springer Publishing Company

Access to resources Recommend Favorite

Effects of a Lytic Peptide Conjugated to hCG on Ovarian Cancer: Studies in Vitro and in Vivo

By Gawronska B.   Leuschner C.   Enright F.M.   Hansel W.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 45-52

Elsevier

Access to resources Recommend Favorite